Key statistics
On Friday, Cytek Biosciences Inc (CTKB:NSQ) closed at 5.01, 31.84% above the 52 week low of 3.80 set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.89 |
---|---|
High | 5.08 |
Low | 4.87 |
Bid | 4.85 |
Offer | 5.21 |
Previous close | 4.87 |
Average volume | 483.49k |
---|---|
Shares outstanding | 131.51m |
Free float | 120.17m |
P/E (TTM) | -- |
Market cap | 640.43m USD |
EPS (TTM) | -0.1327 USD |
Data delayed at least 15 minutes, as of Oct 11 2024 21:00 BST.
More ▼
Announcements
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
- Cytek Biosciences Announces $50 Million Stock Repurchase Program
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
- Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
- Cytek Biosciences Reports First Quarter 2024 Financial Results
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
- Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
More ▼